Irnocam 40 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Irinotecan (40mg)
Overview Irnocam 40 Injection
Colon and rectal cancer treatment utilizes Irnocam 40 Injection, a medication that inhibits or reduces cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; improper usage or overdosage can lead to severe adverse reactions. While benefits may not be immediately apparent (taking several weeks or months), discontinue use only under medical guidance. Common side effects include tiredness, nausea, vomiting, debility, and alopecia. Irnocam 40 Injection can decrease blood cell counts (red and white), increasing infection vulnerability. Report fever, sore throat, or persistent diarrhea to your doctor immediately. Regular blood tests monitoring blood cells, heart, liver function, and uric acid levels are necessary. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all medications, including those for infections, to your physician. Interactions with other drugs are possible; inform your medical team of all medications. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Uses of Irnocam 40 Injection
Colorectal cancer
Major Benefits of Irnocam 40 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Irnocam 40 Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Irnocam 40 Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strongly discouraged.
How Irnocam 40 Injection works:
Irnocam 40 Injection is a cancer treatment that inhibits topoisomerase I, an enzyme crucial for cancer cell DNA replication. This inhibition restricts cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Irnocam 40 Injection is undetermined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Irnocam 40 Injection to pregnant individuals poses a confirmed risk to the fetus. Its use during pregnancy is therefore contraindicated, except in exceptional life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Always seek medical advice.
Breast feedingUNSAFE
Administering Irnocam 40 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingUNSAFE
Irnocam 40 Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Irnocam 40 Injection appears to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is advised. This medication is contraindicated for dialysis patients.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Irnocam 40 Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Irnocam 40 Injection :
Should you forget a scheduled dose of Irnocam 40 Injection, seek your physician's advice.
Facts to Know About Irnocam 40 Injection
| Label | Value |
|---|---|
| Chemical Category | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Topoisomerase inhibitor |
3,018 People bought this recently